MHRA clears inavolisib, offering new option for returning breast cancer
The oral, film-coated tablet is licensed for patients whose cancer has returned during or shortly after hormone therapy
The oral, film-coated tablet is licensed for patients whose cancer has returned during or shortly after hormone therapy
Abdomen-pelvis CT is the nation’s highest-volume CT category
Amrutanjan is also rolling out its new campaign, 'Har Dard Mitaye'
This distinction is testament to LHWRF's dedication to excellence, transparency, and impact in the realm of social responsibility
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
Owlet’s push comes as parents demand smarter, more dependable nursery tech
Subscribe To Our Newsletter & Stay Updated